Tauroursodeoxycholic acid

Tauroursodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Tauroursodeoxycholic acid is associated with abnormalities such as Hyperglycemia, Obesity, Wiskott-Aldrich Syndrome, neurogenic hypertension and Cholestatic liver disease. The involved functions are known as Cell Death, Apoptosis, Homeostasis, Process and mRNA Expression. Tauroursodeoxycholic acid often locates in Body tissue, Endoplasmic Reticulum, Hepatic, Blood and Protoplasm. The associated genes with Tauroursodeoxycholic acid are Homologous Gene and Mutant Proteins. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Tauroursodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is suspected in Endothelial dysfunction, Hyperglycemia, Obesity, neurogenic hypertension, Cholestatic liver disease, Heart failure and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tauroursodeoxycholic acid

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Insulin Resistance D007333 99 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with Tauroursodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tauroursodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tauroursodeoxycholic acid?

Disease model

Disease model are used in the study 'Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.' (Cortez LM et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tauroursodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 531
Authors Title Published Journal PubMed Link
Colell A et al. Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione. 2001 Hepatology pmid:11679967
Heubi JE et al. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. 2002 J. Pediatr. pmid:12183720
Duan WM et al. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease. 2002 Cell Transplant pmid:12075985
Xiao ZL et al. Effects of bile acids on the muscle functions of guinea pig gallbladder. 2002 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12065295
Glasova H et al. Tauroursodeoxycholic acid mobilizes alpha-PKC after uptake in human HepG2 hepatoma cells. 2002 Eur. J. Clin. Invest. pmid:12059989
Noé J et al. Functional expression of the canalicular bile salt export pump of human liver. 2002 Gastroenterology pmid:12404240
Piepoli AL et al. Tauroursodeoxycholic acid reduces damaging effects of taurodeoxycholic acid on fundus gastric mucosa. 2002 Arch. Physiol. Biochem. pmid:12221520
Pandak WM et al. Regulation of oxysterol 7alpha-hydroxylase (CYP7B1) in primary cultures of rat hepatocytes. 2002 Hepatology pmid:12029625
Azzaroli F et al. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. 2002 Hepatology pmid:12085348
Milkiewicz P et al. Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways. 2002 Gut pmid:12077103
Graf D et al. Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. 2002 Gastroenterology pmid:11984527
Yamashita Y et al. High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture system in plasma from patients with fulminant hepatic failure. 2002 Cell Transplant pmid:12162378
Veggi LM et al. Dapsone-induced cholestasis and impairment of bile salt output in the rat. 2002 Biochem. Pharmacol. pmid:11996898
Kim YH and Shin MJ Effects of high taurocholate load on activities of hepatic alcohol metabolizing enzymes. 2002 Exp. Mol. Med. pmid:12085987
Rodrigues CM et al. Neuroprotection by a bile acid in an acute stroke model in the rat. 2002 J. Cereb. Blood Flow Metab. pmid:11919517
Carubbi F et al. Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 2002 Biochim. Biophys. Acta pmid:11923098
Xie Q et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. 2002 Hepatology pmid:12198651
Venneman NG et al. Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles. 2002 Biochim. Biophys. Acta pmid:12117566
Keene CD et al. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12149470
Alpini G et al. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. 2002 Hepatology pmid:11981754
Kok T et al. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. 2003 Biochem. J. pmid:12381268
Rodrigues CM et al. Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria. 2003 Biochemistry pmid:12627974
Rodrigues CM et al. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12721362
Häussinger D et al. Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis. 2003 Gastroenterology pmid:12730886
Baiocchi L et al. Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats. 2003 J. Hepatol. pmid:12547401
Chen W et al. Bile acids for viral hepatitis. 2003 Cochrane Database Syst Rev pmid:12804455
Chignard N et al. Bile salts potentiate adenylyl cyclase activity and cAMP-regulated secretion in human gallbladder epithelium. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12421748
Tessier E et al. High-performance liquid chromatographic mass spectrometric method for the determination of ursodeoxycholic acid and its glycine and taurine conjugates in human plasma. 2003 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:14643509
Schoemaker MH et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. 2003 J. Hepatol. pmid:12873810
Komichi D et al. Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes. 2003 Dig. Dis. Sci. pmid:14714619
Beuers U et al. Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. 2003 J. Biol. Chem. pmid:12626520
Reinehr R et al. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. 2003 Gastroenterology pmid:12949729
Ma J et al. Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells. 2003 Eur. J. Pharmacol. pmid:12620498
Tsuboi K et al. Hydrophilic bile salts have a cytoprotective effect against cyclosporine A-induced cholestasis through enhanced canalicular membrane fluidity and transporter activity. 2003 Hepatol. Res. pmid:12644037
Sánchez Pozzi EJ et al. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. 2003 J. Pharmacol. Exp. Ther. pmid:12663690
Lamireau T et al. Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. 2003 Life Sci. pmid:12527037
Liu Y et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. 2003 J. Clin. Invest. pmid:14623915
Solá S et al. Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway. 2003 Sep-Dec Mol. Med. pmid:15208744
Castro RE et al. The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. 2004 J. Pharmacol. Exp. Ther. pmid:15190125
Ramalho RM et al. Inhibition of the E2F-1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells. 2004 J. Neurochem. pmid:15255934
Kubitz R et al. Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. 2004 Gastroenterology pmid:14762791
Solá S et al. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes. 2004 Biochemistry pmid:15222754
Klett EL et al. A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. 2004 BMC Med pmid:15040800
Schoemaker MH et al. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. 2004 Hepatology pmid:15185297
Lee DK et al. [Deoxycholic acid-induced signal transduction in HT-29 cells: role of NF-kappa B and interleukin-8]. 2004 Korean J Gastroenterol pmid:15034288
Henzel K et al. Toxicity of ethanol and acetaldehyde in hepatocytes treated with ursodeoxycholic or tauroursodeoxycholic acid. 2004 Biochim. Biophys. Acta pmid:14741743
Ma J et al. Ursodeoxycholic acid inhibits endothelin-1 production in human vascular endothelial cells. 2004 Eur. J. Pharmacol. pmid:15556138
Marumo T et al. Biliary excretion of bile acids and organic anions in rats with dichloroethylene-induced bile canalicular injury. 2004 J. Gastroenterol. pmid:15549452
Rolo AP et al. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis. 2004 Toxicol. Sci. pmid:14976352
Tachizawa H et al. Effects of colchicine on the maximum biliary excretion of cholephilic compounds in rats. 2004 J. Gastroenterol. Hepatol. pmid:15304119